首頁 > 市場調查報告書 > 醫療設備

體外診斷生技設備

市場調查報告書

商品編碼

1905177

日本組織診斷市場報告（按產品類型、技術、疾病、最終用戶和地區分類，2026-2034 年）

Japan Tissue Diagnostics Market Report by Product Type, Technology, Disease, End User, and Region 2026-2034

出版日期: 2026年01月01日 | 出版商:

IMARC | 英文 117 Pages | 商品交期: 5-7個工作天內

價格

簡介目錄

2025年，日本組織診斷市場規模達2.59億美元。展望未來， IMARC Group預計到2034年，該市場規模將達到4.464億美元，2026年至2034年期間的複合年成長率（CAGR）為6.24%。數位病理學、次世代定序（NGS）和先進影像技術等技術的不斷進步，提高了組織診斷的準確性和效率，是推動市場成長的主要因素。

本報告解答的關鍵問題：

日本組織診斷市場目前表現如何？未來幾年又將如何發展？
新冠疫情對日本組織診斷市場產生了哪些影響？
日本組織診斷市場依產品類型分類的組成是怎樣的？
日本組織診斷市場依技術分類的組成是怎樣的？
日本組織診斷市場依疾病分類的組成是怎樣的？
日本組織診斷市場依最終使用者分類的組成是怎樣的？
日本組織診斷市場價值鏈的各個階段有哪些？
日本組織診斷的關鍵促進因素和挑戰是什麼？
日本組織診斷市場的結構是怎麼樣的？主要參與者有哪些？
日本組織診斷市場的競爭程度如何？

Japan tissue diagnostics market size reached USD 259.0 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 446.4 Million by 2034, exhibiting a growth rate (CAGR) of 6.24% during 2026-2034. The rising advances in technology, such as digital pathology, next-generation sequencing (NGS), and advanced imaging techniques, which have improved the accuracy and efficiency of tissue diagnostics, are driving the market.

Tissue diagnostics is a crucial field in medicine that involves the microscopic examination and analysis of tissue samples to diagnose diseases and provide insights into their underlying causes. It plays a fundamental role in identifying various medical conditions, including cancer, infections, inflammatory disorders, and autoimmune diseases. The process typically begins with the collection of tissue specimens obtained through procedures like biopsies or surgeries. These samples are then processed, embedded in paraffin wax, sliced into thin sections, and stained with specific dyes to enhance visibility under a microscope. Skilled pathologists and histotechnologists examine these stained tissue sections to identify abnormal cellular structures, patterns, and markers. Tissue diagnostics help clinicians make informed decisions about patient treatment plans, including the choice of therapies, surgeries, or medications. Advances in technology, such as immunohistochemistry and molecular testing, have further improved the precision and specificity of tissue diagnostics, enabling personalized medicine approaches. This field continues to evolve, contributing significantly to early disease detection, prognosis prediction, and tailored patient care.

Japan Tissue Diagnostics Market Trends:

The tissue diagnostics market in Japan is experiencing substantial growth, primarily driven by several key factors. Firstly, the increasing prevalence of cancer necessitates advanced diagnostic techniques, fostering a surge in demand for tissue diagnostics. Additionally, the burgeoning geriatric population, who are more susceptible to chronic diseases, further propels this demand. Furthermore, technological advancements in the realm of molecular diagnostics have revolutionized tissue-based testing, rendering it more efficient and accurate. Also, there has been a significant rise in the awareness of personalized medicine among patients and healthcare providers alike. This has led to an increased emphasis on early disease detection and treatment customization, emphasizing the critical role of tissue diagnostics. Moreover, initiatives by government and private organizations to provide funding and grants for research in cancer diagnostics undeniably spur market growth. Apart from this, the continuous evolution in biomarker identification that is bolstering the development of new diagnostic tools is expected to drive the tissue diagnostics market in Japan.

Japan Tissue Diagnostics Market Segmentation: -

Product Type Insights:

Instruments
Consumables

Technology Insights:

Immunohistochemistry
In Situ Hybridization
Digital Pathology and Workflow Management
Special Staining

Disease Insights:

Breast Cancer
Gastric Cancer
Lymphoma
Prostate Cancer
Non-Small Cell Lung Cancer
Others

End User Insights:

Hospitals
Research Laboratories
Pharmaceutical Companies
Contract Research Organizations
Others

Regional Insights:

Kanto Region
Kansai/Kinki Region
Central/ Chubu Region
Kyushu-Okinawa Region
Tohoku Region
Chugoku Region
Hokkaido Region
Shikoku Region
The report has also provided a comprehensive analysis of all the major regional markets, which include Kanto Region, Kansai/Kinki Region, Central/ Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, and Shikoku Region.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

How has the Japan tissue diagnostics market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the Japan tissue diagnostics market?
What is the breakup of the Japan tissue diagnostics market on the basis of product type?
What is the breakup of the Japan tissue diagnostics market on the basis of technology?
What is the breakup of the Japan tissue diagnostics market on the basis of disease?
What is the breakup of the Japan tissue diagnostics market on the basis of end user?
What are the various stages in the value chain of the Japan tissue diagnostics market?
What are the key driving factors and challenges in the Japan tissue diagnostics?
What is the structure of the Japan tissue diagnostics market and who are the key players?
What is the degree of competition in the Japan tissue diagnostics market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Japan Tissue Diagnostics Market - Introduction

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Japan Tissue Diagnostics Market Landscape

5.1 Historical and Current Market Trends (2020-2025)
5.2 Market Forecast (2026-2034)

6 Japan Tissue Diagnostics Market - Breakup by Product Type

6.1 Instruments
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2020-2025)
- 6.1.3 Market Forecast (2026-2034)
6.2 Consumables
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2020-2025)
- 6.2.3 Market Forecast (2026-2034)

7 Japan Tissue Diagnostics Market - Breakup by Technology

7.1 Immunohistochemistry
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2020-2025)
- 7.1.3 Market Forecast (2026-2034)
7.2 In Situ Hybridization
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2020-2025)
- 7.2.3 Market Forecast (2026-2034)
7.3 Digital Pathology and Workflow Management
- 7.3.1 Overview
- 7.3.2 Historical and Current Market Trends (2020-2025)
- 7.3.3 Market Forecast (2026-2034)
7.4 Special Staining
- 7.4.1 Overview
- 7.4.2 Historical and Current Market Trends (2020-2025)
- 7.4.3 Market Forecast (2026-2034)

8 Japan Tissue Diagnostics Market - Breakup by Disease

8.1 Breast Cancer
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2020-2025)
- 8.1.3 Market Forecast (2026-2034)
8.2 Gastric Cancer
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2020-2025)
- 8.2.3 Market Forecast (2026-2034)
8.3 Lymphoma
- 8.3.1 Overview
- 8.3.2 Historical and Current Market Trends (2020-2025)
- 8.3.3 Market Forecast (2026-2034)
8.4 Prostate Cancer
- 8.4.1 Overview
- 8.4.2 Historical and Current Market Trends (2020-2025)
- 8.4.3 Market Forecast (2026-2034)
8.5 Non-Small Cell Lung Cancer
- 8.5.1 Overview
- 8.5.2 Historical and Current Market Trends (2020-2025)
- 8.5.3 Market Forecast (2026-2034)
8.6 Others
- 8.6.1 Historical and Current Market Trends (2020-2025)
- 8.6.2 Market Forecast (2026-2034)

9 Japan Tissue Diagnostics Market - Breakup by End User

9.1 Hospitals
- 9.1.1 Overview
- 9.1.2 Historical and Current Market Trends (2020-2025)
- 9.1.3 Market Forecast (2026-2034)
9.2 Research Laboratories
- 9.2.1 Overview
- 9.2.2 Historical and Current Market Trends (2020-2025)
- 9.2.3 Market Forecast (2026-2034)
9.3 Pharmaceutical Companies
- 9.3.1 Overview
- 9.3.2 Historical and Current Market Trends (2020-2025)
- 9.3.3 Market Forecast (2026-2034)
9.4 Contract Research Organizations
- 9.4.1 Overview
- 9.4.2 Historical and Current Market Trends (2020-2025)
- 9.4.3 Market Forecast (2026-2034)
9.5 Others
- 9.5.1 Historical and Current Market Trends (2020-2025)
- 9.5.2 Market Forecast (2026-2034)

10 Japan Tissue Diagnostics Market - Breakup by Region

10.1 Kanto Region
- 10.1.1 Overview
- 10.1.2 Historical and Current Market Trends (2020-2025)
- 10.1.3 Market Breakup by Product Type
- 10.1.4 Market Breakup by Technology
- 10.1.5 Market Breakup by Disease
- 10.1.6 Market Breakup by End User
- 10.1.7 Key Players
- 10.1.10 Market Forecast (2026-2034)
10.2 Kansai/Kinki Region
- 10.2.1 Overview
- 10.2.2 Historical and Current Market Trends (2020-2025)
- 10.2.3 Market Breakup by Product Type
- 10.2.4 Market Breakup by Technology
- 10.2.5 Market Breakup by Disease
- 10.2.6 Market Breakup by End User
- 10.2.7 Key Players
- 10.2.8 Market Forecast (2026-2034)
10.3 Central/ Chubu Region
- 10.3.1 Overview
- 10.3.2 Historical and Current Market Trends (2020-2025)
- 10.3.3 Market Breakup by Product Type
- 10.3.4 Market Breakup by Technology
- 10.3.5 Market Breakup by Disease
- 10.3.6 Market Breakup by End User
- 10.3.7 Key Players
- 10.3.8 Market Forecast (2026-2034)
10.4 Kyushu-Okinawa Region
- 10.4.1 Overview
- 10.4.2 Historical and Current Market Trends (2020-2025)
- 10.4.3 Market Breakup by Product Type
- 10.4.4 Market Breakup by Technology
- 10.4.5 Market Breakup by Disease
- 10.4.6 Market Breakup by End User
- 10.4.7 Key Players
- 10.4.8 Market Forecast (2026-2034)
10.5 Tohoku Region
- 10.5.1 Overview
- 10.5.2 Historical and Current Market Trends (2020-2025)
- 10.5.3 Market Breakup by Product Type
- 10.5.4 Market Breakup by Technology
- 10.5.5 Market Breakup by Disease
- 10.5.6 Market Breakup by End User
- 10.5.7 Key Players
- 10.5.8 Market Forecast (2026-2034)
10.6 Chugoku Region
- 10.6.1 Overview
- 10.6.2 Historical and Current Market Trends (2020-2025)
- 10.6.3 Market Breakup by Product Type
- 10.6.4 Market Breakup by Technology
- 10.6.5 Market Breakup by Disease
- 10.6.6 Market Breakup by End User
- 10.6.7 Key Players
- 10.6.8 Market Forecast (2026-2034)
10.7 Hokkaido Region
- 10.7.1 Overview
- 10.7.2 Historical and Current Market Trends (2020-2025)
- 10.7.3 Market Breakup by Product Type
- 10.7.4 Market Breakup by Technology
- 10.7.5 Market Breakup by Disease
- 10.7.6 Market Breakup by End User
- 10.7.7 Key Players
- 10.7.8 Market Forecast (2026-2034)
10.8 Shikoku Region
- 10.8.1 Overview
- 10.8.2 Historical and Current Market Trends (2020-2025)
- 10.8.3 Market Breakup by Product Type
- 10.8.4 Market Breakup by Technology
- 10.8.5 Market Breakup by Disease
- 10.8.6 Market Breakup by End User
- 10.8.7 Key Players
- 10.8.8 Market Forecast (2026-2034)

11 Japan Tissue Diagnostics Market - Competitive Landscape

11.1 Overview
11.2 Market Structure
11.3 Market Player Positioning
11.4 Top Winning Strategies
11.5 Competitive Dashboard
11.6 Company Evaluation Quadrant

12 Profiles of Key Players

12.1 Company A
- 12.1.1 Business Overview
- 12.1.2 Product Portfolio
- 12.1.3 Business Strategies
- 12.1.4 SWOT Analysis
- 12.1.5 Major News and Events
12.2 Company B
- 12.2.1 Business Overview
- 12.2.2 Product Portfolio
- 12.2.3 Business Strategies
- 12.2.4 SWOT Analysis
- 12.2.5 Major News and Events
12.3 Company C
- 12.3.1 Business Overview
- 12.3.2 Product Portfolio
- 12.3.3 Business Strategies
- 12.3.4 SWOT Analysis
- 12.3.5 Major News and Events
12.4 Company D
- 12.4.1 Business Overview
- 12.4.2 Product Portfolio
- 12.4.3 Business Strategies
- 12.4.4 SWOT Analysis
- 12.4.5 Major News and Events
12.5 Company E
- 12.5.1 Business Overview
- 12.5.2 Product Portfolio
- 12.5.3 Business Strategies
- 12.5.4 SWOT Analysis
- 12.5.5 Major News and Events

13 Japan Tissue Diagnostics Market - Industry Analysis

13.1 Drivers, Restraints, and Opportunities
- 13.1.1 Overview
- 13.1.2 Drivers
- 13.1.3 Restraints
- 13.1.4 Opportunities
13.2 Porters Five Forces Analysis
- 13.2.1 Overview
- 13.2.2 Bargaining Power of Buyers
- 13.2.3 Bargaining Power of Suppliers
- 13.2.4 Degree of Competition
- 13.2.5 Threat of New Entrants
- 13.2.6 Threat of Substitutes
13.3 Value Chain Analysis